Perbedaan Puradelta Lestari Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Puradelta Lestari Tbk. diperdagangkan di Rp137 (kapitalisasi pasar 6,6 T, volume 24 jam 40,24 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Puradelta Lestari Tbk. jauh lebih besar — sekitar 39,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Puradelta Lestari Tbk. lebih aktif diperdagangkan (40,24 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DMAS | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 6,6 T | 167,37 M |
Volume | 40,24 jt | 71 rb |
Lot | 402,39 rb | 710 |
Perputaran | 5,52 M | 17,51 jt |
Harga Rata-rata | 137,3 | 246,63 |
Nilai Transaksi | 5,52 M | 17,51 jt |
Harga Ekuilibrium Indikatif | 137 | 246 |
Volume Ekuilibrium Indikatif | 9,27 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Selengkapnya di halaman DMAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →